Literature DB >> 25934456

3D culture broadly regulates tumor cell hypoxia response and angiogenesis via pro-inflammatory pathways.

Peter DelNero1, Maureen Lane2, Scott S Verbridge3, Brian Kwee1, Pouneh Kermani2, Barbara Hempstead2, Abraham Stroock4, Claudia Fischbach5.   

Abstract

Oxygen status and tissue dimensionality are critical determinants of tumor angiogenesis, a hallmark of cancer and an enduring target for therapeutic intervention. However, it is unclear how these microenvironmental conditions interact to promote neovascularization, due in part to a lack of comprehensive, unbiased data sets describing tumor cell gene expression as a function of oxygen levels within three-dimensional (3D) culture. Here, we utilized alginate-based, oxygen-controlled 3D tumor models to study the interdependence of culture context and the hypoxia response. Microarray gene expression analysis of tumor cells cultured in 2D versus 3D under ambient or hypoxic conditions revealed striking interdependence between culture dimensionality and hypoxia response, which was mediated in part by pro-inflammatory signaling pathways. In particular, interleukin-8 (IL-8) emerged as a major player in the microenvironmental regulation of the hypoxia program. Notably, this interaction between dimensionality and oxygen status via IL-8 increased angiogenic sprouting in a 3D endothelial invasion assay. Taken together, our data suggest that pro-inflammatory pathways are critical regulators of tumor hypoxia response within 3D environments that ultimately impact tumor angiogenesis, potentially providing important therapeutic targets. Furthermore, these results highlight the importance of pathologically relevant tissue culture models to study the complex physical and chemical processes by which the cancer microenvironment mediates new vessel formation.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  3D culture; Angiogenesis; Cancer microenvironment; Hypoxia; Inflammation; Tissue engineering

Mesh:

Substances:

Year:  2015        PMID: 25934456      PMCID: PMC4417672          DOI: 10.1016/j.biomaterials.2015.03.035

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  54 in total

1.  Molecular heterogeneity of tumor endothelium.

Authors:  William C Aird
Journal:  Cell Tissue Res       Date:  2008-08-23       Impact factor: 5.249

2.  Interstitial fluid pressure as an alternate regulator of angiogenesis independent of hypoxia driven HIF-1α in solid tumors.

Authors:  Khin Zarchi Aung; Barry P Pereira; Pamela H S Tan; Hwan-Chour Han; Saminathan S Nathan
Journal:  J Orthop Res       Date:  2012-05-23       Impact factor: 3.494

3.  Interleukin 8 in human hepatocellular carcinoma correlates with cancer cell invasion of vessels but not with tumor angiogenesis.

Authors:  Fumitake Kubo; Shinichi Ueno; Kiyokazu Hiwatashi; Masahiko Sakoda; Koichi Kawaida; Kensuke Nuruki; Takashi Aikou
Journal:  Ann Surg Oncol       Date:  2005-08-09       Impact factor: 5.344

4.  Hypoxia-induced elevation in interleukin-8 expression by human ovarian carcinoma cells.

Authors:  L Xu; K Xie; N Mukaida; K Matsushima; I J Fidler
Journal:  Cancer Res       Date:  1999-11-15       Impact factor: 12.701

5.  Gene expression profiling allows distinction between primary and metastatic squamous cell carcinomas in the lung.

Authors:  Simon G Talbot; Cherry Estilo; Ellie Maghami; Inderpal S Sarkaria; Duy Khanh Pham; Pornchai O-charoenrat; Nicholas D Socci; Ivan Ngai; Diane Carlson; Ronald Ghossein; Agnes Viale; Bernard J Park; Valerie W Rusch; Bhuvanesh Singh
Journal:  Cancer Res       Date:  2005-04-15       Impact factor: 12.701

6.  The intratumoral expression of vascular endothelial growth factor and interleukin-8 associated with angiogenesis in nonsmall cell lung carcinoma patients.

Authors:  D Masuya; C Huang; D Liu; K Kameyama; E Hayashi; A Yamauchi; S Kobayashi; R Haba; H Yokomise
Journal:  Cancer       Date:  2001-11-15       Impact factor: 6.860

7.  Interleukin-8 as a modulator of response to bevacizumab in preclinical models of head and neck squamous cell carcinoma.

Authors:  Rekha Gyanchandani; Daisuke Sano; Marcus V Ortega Alves; Jonah D Klein; Beth A Knapick; Sanders Oh; Jeffrey N Myers; Seungwon Kim
Journal:  Oral Oncol       Date:  2013-04-24       Impact factor: 5.337

Review 8.  The organizing principle: microenvironmental influences in the normal and malignant breast.

Authors:  Mina J Bissell; Derek C Radisky; Aylin Rizki; Valerie M Weaver; Ole W Petersen
Journal:  Differentiation       Date:  2002-12       Impact factor: 3.880

9.  Pathway-specific differences between tumor cell lines and normal and tumor tissue cells.

Authors:  Adam Ertel; Arun Verghese; Stephen W Byers; Michael Ochs; Aydin Tozeren
Journal:  Mol Cancer       Date:  2006-11-02       Impact factor: 27.401

10.  Integrin LFA-1 interacts with the transcriptional co-activator JAB1 to modulate AP-1 activity.

Authors:  E Bianchi; S Denti; A Granata; G Bossi; J Geginat; A Villa; L Rogge; R Pardi
Journal:  Nature       Date:  2000-04-06       Impact factor: 49.962

View more
  50 in total

1.  Adipose-derived stem cells increase angiogenesis through matrix metalloproteinase-dependent collagen remodeling.

Authors:  Young Hye Song; Seung Hee Shon; Mengrou Shan; Abraham D Stroock; Claudia Fischbach
Journal:  Integr Biol (Camb)       Date:  2016-01-13       Impact factor: 2.192

Review 2.  Cancer metabolism gets physical.

Authors:  Peter DelNero; Benjamin D Hopkins; Lewis C Cantley; Claudia Fischbach
Journal:  Sci Transl Med       Date:  2018-05-23       Impact factor: 17.956

Review 3.  Biomaterials approaches to modeling macrophage-extracellular matrix interactions in the tumor microenvironment.

Authors:  Nora L Springer; Claudia Fischbach
Journal:  Curr Opin Biotechnol       Date:  2016-02-25       Impact factor: 9.740

Review 4.  3D bioprinting of glioblastoma models.

Authors:  Carolina Parra-Cantu; Wanlu Li; Alfredo Quiñones-Hinojosa; Yu Shrike Zhang
Journal:  J 3D Print Med       Date:  2020-10-28

Review 5.  Microphysiological Human Brain and Neural Systems-on-a-Chip: Potential Alternatives to Small Animal Models and Emerging Platforms for Drug Discovery and Personalized Medicine.

Authors:  Alexander P Haring; Harald Sontheimer; Blake N Johnson
Journal:  Stem Cell Rev Rep       Date:  2017-06       Impact factor: 5.739

6.  Three dimensional engineered models to study hypoxia biology in breast cancer.

Authors:  Vaishali Aggarwal; Oshin Miranda; Paul A Johnston; Shilpa Sant
Journal:  Cancer Lett       Date:  2020-06-20       Impact factor: 8.679

7.  Hypoxia differentially regulates estrogen receptor alpha in 2D and 3D culture formats.

Authors:  Nathan A Whitman; Zhi-Wei Lin; Rachael M Kenney; Leonardo Albertini; Matthew R Lockett
Journal:  Arch Biochem Biophys       Date:  2019-06-01       Impact factor: 4.013

8.  Hypoxia alters the release and size distribution of extracellular vesicles in pancreatic cancer cells to support their adaptive survival.

Authors:  Mary C Patton; Haseeb Zubair; Mohammad Aslam Khan; Seema Singh; Ajay P Singh
Journal:  J Cell Biochem       Date:  2019-08-12       Impact factor: 4.429

9.  O2-controllable hydrogels for studying cellular responses to hypoxic gradients in three dimensions in vitro and in vivo.

Authors:  Daniel M Lewis; Michael R Blatchley; Kyung Min Park; Sharon Gerecht
Journal:  Nat Protoc       Date:  2017-07-20       Impact factor: 13.491

10.  Hydroxyapatite mineral enhances malignant potential in a tissue-engineered model of ductal carcinoma in situ (DCIS).

Authors:  Frank He; Nora L Springer; Matthew A Whitman; Siddharth P Pathi; Yeonkyung Lee; Sunish Mohanan; Stephen Marcott; Aaron E Chiou; Bryant S Blank; Neil Iyengar; Patrick G Morris; Maxine Jochelson; Clifford A Hudis; Pragya Shah; Jennie A M R Kunitake; Lara A Estroff; Jan Lammerding; Claudia Fischbach
Journal:  Biomaterials       Date:  2019-09-11       Impact factor: 12.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.